BackBiostar Pharmaceuticals Overview

Biostar Pharmaceuticals Long Term Debt

Biostar Pharmaceuticals's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Biostar Pharmaceuticals Long Term Debt History

Loading

Biostar Pharmaceuticals vs. peers: Long Term Debt Comparison

Loading

Biostar Pharmaceuticals Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biostar Pharmaceuticals (BSPM) FAQ

Biostar Pharmaceuticals posts a long-term debt of $0 as of September 2017. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Biostar Pharmaceuticals's long-term debt was $0. The latest reading is $0 (period ending September 2017). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Biostar Pharmaceuticals's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BSPM's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Biostar Pharmaceuticals's other metric pages and overview cover the third.